A new drug for triple-negative breast cancer?
- Researcher: Professor David Vaux
- Institution: The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia
- Award Amount: £194,852 over 3 years from January 2015
- Cancer Type: Breast Cancer
However, Professor Vaux and his team have gathered exciting early data which suggests that a new type of targeted drug called birinapant could be particularly effective on triple-negative breast cancer. For this project they will now take this further. Professor Vaux explains: "In this project we want to confirm our earlier birinapant findings by using a special mouse model with patient-derived breast tumours. We will also test the combination of birinapant with other drugs, to optimise its effectiveness. It's really exciting- if our work is successful, these results will provide the basis for a phase 2 clinical trials."
Showing: All projects
The Research That Is Happening Right Now
Explore current projects to see how far-reaching our research is from a global perspective.
See the difference our research projects make.
Our philosophy is very simple: if we believe a project can make a difference in the fight against cancer then we will award a grant to make it happen. We’re not interested in national borders or any kind of geographical bias, just the most promising proposals. And that’s the very reason we ask t...Read more
Life in the Lab
Supporters often ask us what type of projects their donations are funding. What does a typical day in the life of a cancer researcher look like? To answer these questions and give you an insight into the vital work your support helps us to fund, we've put together this short video....Read more